Jessica Jean, Martha Estrella Garcia-Pérez and Roxane Pouliot
Tissue-engineered skin substitutes represent an innovative therapeutic option for the treatment of burns and
skin ulcers as well as a powerful tool for fundamental research. To be efficient, in vitro skin substitutes must closely
mimic human skin structures and exogenous material has to be reduced as much as possible. The self-assembly
approach is based on the capacity of fibroblasts to create their own extracellular matrix in vitro, which allows the
production of cell sheets that are easy to handle. Therefore, a skin substitute devoid of exogenous extracellular
matrix proteins and synthetic material is produced, which demonstrates many histological, physico-chemical and
mechanical characteristics found in normal human skin in vivo. A particularity of this approach is the possibility to
add various other cell types (keratinocytes, melanocytes, adipocytes, endothelial and immunological cells, etc.)
according to needs. Furthermore, pathological cells (hypertrophic scar, sclerodermic, tumoral and psoriatic cells)
can be used for the production of pathological skin substitutes. The development of these models represents a key
component in the fight against such diseases because they can lead to a better understanding of the pathology
and to the development of new pharmaceutical therapies.This review will present the need for tissue-engineered
skin substitutes, the implication of tissue engineering in the cutaneous field (basic and applied research), the selfassembly
approach and its characteristics as well as the actual state of research on healthy and pathological selfassembled
skin models.
Share this article
Journal of Tissue Science and Engineering received 807 citations as per Google Scholar report